We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

115 hedge funds and large institutions have $150M invested in VanEck Biotech ETF in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 32 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 13

0% more funds holding

Funds holding: 115 → 115 (0)

1% less capital invested

Capital invested by funds: $152M → $150M (-$1.49M)

25% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 32

40.53% less ownership

Funds ownership: 78.34% → 37.81% (-41%)

Holders
115
Holders Change
–
Holders Change %
0%
% of All Funds
1.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
24
Reduced
32
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TWC
TD Waterhouse Canada
Ontario, Canada
+$10.7M
2
Bank of America
Bank of America
North Carolina
+$6.74M
3
Morgan Stanley
Morgan Stanley
New York
+$3.25M
4
ACA
Atlas Capital Advisors
Wyoming
+$959K
5
TAM
Tocqueville Asset Management
New York
+$922K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$2.7M
2
GT
Glenview Trust
Kentucky
-$1.65M
3
Jane Street
Jane Street
New York
-$1.48M
4
MIM
Miller Investment Management
Pennsylvania
-$1.28M
5
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
-$662K
Name Holding Trade Value Shares
Change 		Change in
Stake
LJAC
26
L.J. Altfest & Co
New York
$1.04M -$15.8K -94 -1%
Cerity Partners
27
Cerity Partners
New York
$959K – – –
Wealthfront Advisers
28
Wealthfront Advisers
California
$910K +$212K +1,261 +28%
Citadel Advisors
29
Citadel Advisors
Florida
$907K -$2.7M -16,038 -74%
ACA
30
Atlas Capital Advisors
Wyoming
$895K +$959K +5,700 New
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$863K +$610K +3,628 +194%
TAM
32
Tocqueville Asset Management
New York
$860K +$922K +5,478 New
CIBC Private Wealth Group
33
CIBC Private Wealth Group
Georgia
$796K – – –
PSF
34
Pacific Sun Financial
California
$784K -$113K -674 -12%
KAS
35
Kestra Advisory Services
Texas
$717K -$143K -851 -16%
AL
36
Aspiriant LLC
California
$680K – – –
PNC Financial Services Group
37
PNC Financial Services Group
Pennsylvania
$628K – – –
NWA
38
Navis Wealth Advisors
New York
$624K +$5.21K +31 +0.8%
Kovitz Investment Group Partners
39
Kovitz Investment Group Partners
Illinois
$500K – – –
Janney Montgomery Scott
40
Janney Montgomery Scott
Pennsylvania
$481K +$516K +3,065 New
Cetera Investment Advisers
41
Cetera Investment Advisers
Illinois
$419K +$68K +404 +18%
Truist Financial
42
Truist Financial
North Carolina
$413K -$16.1K -96 -4%
Jones Financial Companies
43
Jones Financial Companies
Missouri
$411K -$18.2K -108 -4%
TRCT
44
Tower Research Capital (TRC)
New York
$408K +$118K +702 +37%
Wealth Enhancement Advisory Services
45
Wealth Enhancement Advisory Services
Minnesota
$356K – – –
WJWM
46
Williams Jones Wealth Management
New York
$345K – – –
PVI
47
Pine Valley Investments
New Jersey
$337K -$3.37K -20 -0.9%
Creative Planning
48
Creative Planning
Kansas
$331K +$44.6K +265 +14%
TYCC
49
Texas Yale Capital Corp
Florida
$327K +$60.6K +360 +21%
FHA
50
Flagship Harbor Advisors
Massachusetts
$311K +$36K +214 +12%
1
2
3 4 5

BBH Hedge Fund Activity: Q4 2024 in Review

115 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2024, worth a combined $150M — down 0.98% from $152M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BBH positions and 13 closed out — a net gain of 3 holders — while 24 added to existing stakes and 32 trimmed.

The largest buyer was TD Waterhouse Canada, opening a new position worth an estimated $10.7M. The largest seller was Citadel Advisors, cutting an estimated $2.7M.

  • 115 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $150M of VanEck Biotech ETF stock for Q4 2024, down 0.98% quarter-over-quarter.
  • 16 funds opened new VanEck Biotech ETF positions in Q4 2024 and 13 closed out, a net change of +3 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2024 was TD Waterhouse Canada, an estimated $10.7M added.
  • The largest VanEck Biotech ETF seller in Q4 2024 was Citadel Advisors, an estimated $2.7M sold.

Based on aggregated 13F filings for Q4 2024.